Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank40
3Y CAGR-76.6%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-76.6%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 2.01% |
| 2023 | -13.17% |
| 2022 | 45.10% |
| 2021 | 157.12% |
| 2020 | 60.26% |
| 2019 | 0.00% |